The Global Outbreak Alert and Response Network (GOARN) is a network composed of numerous technical and public health institutions, laboratories, NGOs, and other organizations that work to observe and respond to threatening epidemics. [1] GOARN works closely with and under the World Health Organization (WHO), which is one of its most notable partners. Its goals are to: examine and study diseases, evaluate the risks that certain diseases pose, and improve international capability to deal with diseases. [2]
The World Health Organization realized at the start of the 21st century that it did not have the resources required to adequately respond to and prevent epidemics around the world. Thus, a "Framework for Global Outbreak and Response" was created by the Department of Communicable Diseases Surveillance and Response, and Regional Offices. This framework was put then forth in a meeting in Geneva from April 26–28, 2000. In this meeting, which was attended by 121 representatives from 67 institutions, the decision was made to form GOARN to contribute resources, coordination, surveillance, and technical assistance towards combating diseases. [3]
It was decided that GOARN would be directed by a steering committee made of 20 representatives of GOARN partners and an operational support team (OST) based in WHO. The steering committee oversees and plans the activities of GOARN, and the OST is composed of a minimum of 5–6 WHO staff. Task forces and groups were established to deal with specific issues. [4] GOARN resources are primarily coordinated by the World Health Organization. [3]
The WHO's guiding principles are to standardize "epidemiological, laboratory, clinical management, research, communication, logistics, support, security, evacuation, and communication systems" and coordinative international resources to support local efforts by GOARN partners to combat outbreaks. It also focuses on improving long term ability to provide technical assistance to affected areas. [4]
GOARN has grown to now have over 600 partners in the form of public health institutions, networks, laboratories, and United Nations and non-governmental organizations. Technical institutions, networks, and organizations that have the ability to improve GOARN's capabilities are eligible for partnership. [5] Through its partners, GOARN is staffed by a variety of individuals who specialize in public health, such as "doctors, nurses, infection control specialists, logisticians, laboratory specialists; communication, anthropology and social mobilization experts, emergency management and public health professionals among others." [6]
As its biggest partner, WHO plays a large role in GOARN. Alongside coordinating its resources to combat outbreaks, WHO provides much of the staffing and assistance for GOARN, though as will be covered later, does not fund GOARN directly. Since the network is primarily led by the WHO, there is some uncertainty as to whether WHO should be considered a partner in GOARN or if the network should be considered a WHO initiative.[ citation needed ]
Another notable partner is the Center for Disease Control, which sends technical resources and staff to GOARN. The CDC also has a history of resource sharing and cooperation with WHO in order to combat disease. [7]
The WHO does not directly fund GOARN. Instead, GOARN members and outside fundraising that is carried out each time there is a new incidence is used to support the GOARN response. The Nuclear Threat Initiative provides GOARN with US$500,000 as a revolving fund, meant to be used for quickly mobilizing response teams. This is known as the WHO-NTI Global Emergency Response Fund, and must be repaid after withdrawal. The GOARN is effective at operating from a fairly small budget. [8]
GOARN has responded to over 120 occurrences in 85 countries and has deployed over 2,300 experts into the field. [6] Some examples of deployments are the SARS outbreak in Asia in 2003, Rift Valley fever, and the nipah virus around the Indian subcontinent. [9]
Since its creation, GOARN cooperated with various other organizations to control outbreaks and improve national capacity to respond to diseases. A brief history of GOARN's work against international diseases is as follows. In 2000–2003, GOARN primarily responded to outbreaks of diseases such as cholera, meningitis, and yellow fever in Africa. It supported field investigation and outbreak containment. In 2003, GOARN helped to deploy international teams and helped to coordinate the response against SARS. In 2004, the network was one of the first to deploy against H5N1 influenza. In April–July 2005, GOARN helped to control Marburg Hemorrhagic fever in Angola. It carried out some "risk assessment and preparedness missions" in 2006, along with some response to human bird flu. In 2008/2009, GOARN responded to cholera in Zimbabwe. [10]
GOARN played a role in containing the 2003 SARS outbreak in Asia. The network sent teams of experts in epidemiology, microbiology/virology, and infection control to Hanoi, Vietnam on March 14, 2003 and then Beijing China on March 25, 2003. GOARN assisted during this outbreak to not only study the outbreak and provide assistance, but also facilitate communication between the Department of Health (Hong Kong) and the WHO. [11]
Earliest signs of the outbreak in China were reported February 11–24, when multiple people were reported to contract the disease. WHO was notified February 28 and then directly notified GOARN March 13. The first members of a WHO/GOARN outbreak control team arrived in Hong Kong March 14, followed by another 5-person GOARN team 12 days later. This second team transitioned to Guangdong, where they investigated the earliest cases of SARS and conducted interviews with health staff. The outbreak was declared by WHO to be contained by July 5. [12]
Worldwide, GOARN carried out many of the operations for the initial response to SARS through the mobilization of field teams. Also through GOARN, the WHO developed many international networks to create tools and standards for containing the epidemic. These networks communicated data by teleconference and use of secure websites for sharing of information.[ citation needed ]
Besides these networks and field teams, GOARN also assisted nations by directly providing assistance to affected areas and improving their capacity to respond to such threats in the future. GOARN's role in the outbreak was recognized by the World Health Assembly during the 56th Assembly in resolution WHA56.29. [13]
On March 23, 2014, the first reports of Ebola in Guinea were reported by WHO's Regional Office in Africa. Five days later, the first GOARN team was sent to Guinea. This team found the situation to be quite severe and its findings were discussed in a press conference in Geneva April 8. [14]
In the third week of April, WHO collaborated with GOARN to send a new medical team trained in infection prevention/control and intensive care to Guinea's principal hospital, Donka Hospital. Two weeks later, on May 5, WHO deployed experts, thirty three of whom were from GOARN, to West Africa to assist in the response to the outbreak. The outbreak was detected to have spread to Sierre Leone later in the month. [14]
On June 23, a GOARN steering committee session sent a message to WHO requesting for WHO to lead the response more strongly because it was the only agency with the resources and staff to do so. [14]
Over the course of the outbreak, the network deployed 895 experts, including "doctors, nurses, infection control specialists, logisticians, laboratory specialists; communication, anthropology and social mobilisation experts, emergency management and public health professionals." The network is still involved in the response to Ebola. [15]
In Sierre Leone, GOARN has sent case management and laboratory experts from the International Centre for Diarrhoeal Disease Research, Bangladesh to help train the response capacity of health care and laboratory workers case management and diagnosis. [16]
In Northern Iraq, the Syrian Civil War displaced many refugees into the Kurdistan. The refugee camps suffer from poor sanitation, which has led to cholera outbreaks in the region in 2007 and 2012. GOARN, as per the request of the Ministry of Health of Iraq for support and training in outbreak response, deployed a multidisciplinary team of six experts to the North-Iraqi Dohuk and Erbil camps to assist with assessing the risk of cholera and other diseases as well as assisting MoH to prepare for response to the diseases. [17]
GOARN supported countries and various other outbreak control organizations to fight against the H1N1 outbreak in the US and Mexico. The GOARN alert and request for assistance started in Mexico April 24, 2009. Over the course of the outbreak, GOARN helped the Pan American Health Organization coordinate and exchange information with the CDC and Public Health Agency of Canada. It was provided with support and training from the Regional Office for the Western Pacific Response so that it could support regional offices in Manila and carry out field missions in Malaysia and Mongolia. The network carried out a joint training course with the Regional Office for the Eastern Mediterranean in Cairo. [18]
All in all, GOARN carried out 188 missions to 27 countries to strengthen international coordination between these organizations and to improve international capacity to respond to threats. Its activities consisted of assessment of the situation, communication between partners, infection control, laboratory diagnostic, and transportation of specimens. [18]
Global alert is used as the global radio-communications network during times of international crises or threats to international security. Global Alerts are also issued by agencies such as the World Health Organization (WHO), when there is a perceived threat of international pandemic,, such as the threat of a SARS,, pandemic during March 2003, due to its high contagion level which was rapidly spread by travelers sharing international flights. The global alert released by the World Health Organization regarding the SARS outbreak and its rapid contagion saved many lives: The alert about the disease, precautionary measures, and preventive measures to be taken by individuals, including specific hygiene information needed to arrest the spread of SARS was communicated instantly throughout the world.
David Nabarro CBE is a Special Envoy on Covid-19 for the World Health Organization. He has made his career in the international civil service, working for either the Secretary-General of the United Nations or the Director-General of the World Health Organization. Since February 2020, he has helped the DGWHO deal with the COVID-19 pandemic.
The National Microbiology Laboratory (NML) is part of the Public Health Agency of Canada (PHAC), the agency of the Government of Canada that is responsible for public health, health emergency preparedness and response, and infectious and chronic disease control and prevention.
Disease surveillance is an epidemiological practice by which the spread of disease is monitored in order to establish patterns of progression. The main role of disease surveillance is to predict, observe, and minimize the harm caused by outbreak, epidemic, and pandemic situations, as well as increase knowledge about which factors contribute to such circumstances. A key part of modern disease surveillance is the practice of disease case reporting.
The Association of Public Health Laboratories (APHL) is a membership organization in the United States representing the laboratories that protect the health and safety of the public. APHL serves as a liaison between public health laboratories and federal and international agencies. Membership consists of local, state, county, and territorial public health laboratories; public health environmental, agricultural and veterinary laboratories; and corporations and individuals with an interest in public health and laboratory science. APHL is a non-profit, 501(c)(3) organization with a history of over fifty years.
David L. Heymann is an American infectious disease epidemiologist and public health expert, based in London.
The European Commissioner for Crisis Management is a member of the European Commission. The portfolio was previously titled Commissioner for Humanitarian Aid and Civil Protection. The post is currently held by Janez Lenarčič.
The Global Public Health Intelligence Network (GPHIN) is an electronic public health early warning system developed by Canada's Public Health Agency, and is part of the World Health Organization's (WHO) Global Outbreak Alert and Response Network (GOARN). This system monitors internet media, such as news wires and websites, in nine languages in order to help detect and report potential disease or other health threats around the world. The system has been credited with detecting early signs of the 2009 swine flu pandemic in Mexico, Zika in West Africa, H5N1 in Iran, MERS and Ebola.
The International Health Regulations (IHR), first adopted by the World Health Assembly in 1969 and last revised in 2005, are a legally binding instrument of international law that aims for international collaboration "to prevent, protect against, control, and provide a public health response to the international spread of disease in ways that are commensurate with and restricted to public health risks and that avoid unnecessary interference with international traffic and trade". The IHR is the only international legal treaty with the responsibility of empowering the World Health Organization (WHO) to act as the main global surveillance system.
As of 24 September 2012, a cholera outbreak in Sierra Leone had caused the deaths of 392 people. It was the country's largest outbreak of cholera since first reported in 1970 and the deadliest since the 1994–1995 cholera outbreak. The outbreak has also affected Guinea, which shares a reservoir near the coast. This was the largest cholera outbreak in Africa in 2012.
The United States intelligence community (IC) has a long history of producing assessments on infectious diseases. Most of these papers are distributed to government administrators and inform the choices of policymakers. Three of these assessments stand out as analytical products that have had important impact on the awareness, funding and treatment of infectious diseases around the world. The first paper is the National Intelligence Estimate on the Global Infectious Disease Threat, the second paper is the assessment on the Next Wave of HIV/AIDS, and the third paper was the assessment on SARS. This page summarizes the findings of these three papers and provides information about their impact.
Ebola, also known as Ebola virus disease (EVD) and Ebola hemorrhagic fever (EHF), is a viral hemorrhagic fever in humans and other primates, caused by ebolaviruses. Symptoms typically start anywhere between two days and three weeks after becoming infected with the virus. The first symptoms are usually fever, sore throat, muscle pain, and headaches. These are usually followed by vomiting, diarrhoea, rash and decreased liver and kidney function, at which point, some people begin to bleed both internally and externally. The disease kills between 25% and 90% of those infected—about 50% on average. Death is often due to shock from fluid loss, and typically occurs between six and 16 days after the first symptoms appear.
A Public Health Emergency of International Concern (PHEIC) is a formal declaration by the World Health Organization (WHO) of "an extraordinary event which is determined to constitute a public health risk to other States through the international spread of disease and to potentially require a coordinated international response", formulated when a situation arises that is "serious, sudden, unusual, or unexpected", which "carries implications for public health beyond the affected state's national border" and "may require immediate international action". Under the 2005 International Health Regulations (IHR), states have a legal duty to respond promptly to a PHEIC. The declaration is publicized by an IHR Emergency Committee (EC) of international experts, which was developed following the 2002–2004 SARS outbreak.
Organizations from around the world responded to the West African Ebola virus epidemic. In July 2014, the World Health Organization (WHO) convened an emergency meeting with health ministers from eleven countries and announced collaboration on a strategy to co-ordinate technical support to combat the epidemic. In August, they declared the outbreak an international public health emergency and published a roadmap to guide and coordinate the international response to the outbreak, aiming to stop ongoing Ebola transmission worldwide within 6–9 months. In September, the United Nations Security Council declared the Ebola virus outbreak in the West Africa subregion a "threat to international peace and security" and unanimously adopted a resolution urging UN member states to provide more resources to fight the outbreak; the WHO stated that the cost for combating the epidemic will be a minimum of $1 billion.
Dale Andrew Fisher FRACP is an Australian physician who specialises in Infectious Diseases and is a Senior Consultant in the Division of Infectious Diseases at the National University Hospital, Singapore. He is also a Professor of Medicine at the Yong Loo Lin School of Medicine, National University of Singapore, the chair of the National Infection Prevention and Control Committee through the Ministry of Health, Singapore, and chair of the steering committee of the Global Outbreak Alert and Response Network hosted by the World Health Organization.
Michael Joseph Ryan is an Irish epidemiologist and former trauma surgeon, specialising in infectious disease and public health. He is executive director of the World Health Organization's Health Emergencies Programme, leading the team responsible for the international containment and treatment of COVID-19. Ryan has held leadership positions and has worked on various outbreak response teams in the field to eradicate the spread of diseases including bacillary dysentery, cholera, Crimean–Congo hemorrhagic fever, Ebola, Marburg virus disease, measles, meningitis, relapsing fever, Rift Valley fever, SARS, and Shigellosis.
Trudie Lang is a Professor of Global Health Research at the University of Oxford. She specialises in clinical trials research capacity building in low-resource setting, and helped to organise the trial for the drug brincidofovir during the 2014 Ebola virus outbreak.
Science diplomacy is the collaborative efforts by local and global entities to solve global issues using science and technology as a base. In science diplomacy, collaboration takes place to advance science but science can also be used to facilitate diplomatic relations. This allows even conflicting nations to come together through science to find solutions to global issues. Global organizations, researchers, public health officials, countries, government officials, and clinicians have previously worked together to create effective measures of infection control and subsequent treatment. They continue to do so through sharing of resources, research data, ideas, and by putting into effect laws and regulations that can further advance scientific research. Without the collaborative efforts of such entities, the world would not have the vaccines and treatments we now possess for diseases that were once considered deadly such as tuberculosis, tetanus, polio, influenza, etc. Historically, science diplomacy has proved successful in diseases such as SARS, Ebola, Zika and continues to be relevant during the COVID-19 pandemic today.
Sylvie Champaloux Briand is a French physician who is Director of the Pandemic and Epidemic Diseases Department at the World Health Organization. Briand led the Global Influenza Programme during the 2009 swine flu pandemic. During the COVID-19 pandemic, Briand launched the WHO Information Network for Epidemics which looked to counter the spread of COVID-19 misinformation.